Business Parks & Science Centres



Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4230 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 ... 41 42 43  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel. 2018-01-10
Heptares Therapeutics Ltd.. (1/10/18). "Press Release: Sosei Subsidiary, Heptares, Enters Drug R&D Collaboration with Imperial College London Focused on Multiple GPCR Disease Target Opportunities in the Gastro-intestinal Tract". Tokyo & London. 2018-01-10
Scancell Holdings plc. (1/9/18). "Press Release: Scancell to Collaborate with BioNTech to Investigate T cell Receptor based Therapeutics for the Treatment of Cancer". 2018-01-09
F-Star Biotechnology Ltd.. (1/9/18). "Press Release: F-Star Provides an Update on Its Collaboration with Denali Therapeutics". Cambridge. 2018-01-09
XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation® Technology". Freising. 2018-01-09
Agilent Technologies Inc.. (1/9/18). "Press Release: Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences". Santa Clara, CA. 2018-01-09
Genomics England Ltd.. (1/8/18). "Press Release: Genomics England Adopts Edico Genome’s DRAGEN Bio-IT Platform". 2018-01-08
Adaptimmune Therapeutics plc. (1/8/18). "Press Release: Adaptimmune Announces Two Manufacturing Achievements on Its Way to Become the First Fully Integrated TCR T-cell Therapy Company". Philadeliphia, PA & Oxford. 2018-01-08
Adaptimmune Therapeutics plc. (1/8/18). "Press Release: Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 Billion Target Cell Dose". Philadeliphia, PA & Oxford. 2018-01-08
Storm Therapeutics Ltd.. (1/8/18). "Press Release: Storm Therapeutics Extends Series A Round to Include New Investor Taiho Ventures". Cambridge. 2018-01-08
Celgene Corporation. (1/7/18). "Press Release: Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies". Summit, NJ & San Diego, CA. 2018-01-07
Adaptimmune Therapeutics plc. (1/4/18). "Press Release: Paul Stead Joins Adaptimmune as Vice President of Business Development". Philadeliphia, PA & Oxford. 2018-01-04
Bicycle Therapeutics Ltd.. (1/4/18). "Press Release: Bicycle Therapeutics Secures an Innovate UK Grant to Develop the Next Generation of Antibiotics". Cambridge & Boston, MA. 2018-01-04
Immunocore Ltd.. (1/4/18). "Press Release: Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors". Oxford & Conshohocken, PA. 2018-01-04
Addex Therapeutics S.A.. (1/3/18). "Press Release: Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments". Geneva. 2018-01-03
Autolus Therapeutics Ltd.. (1/2/18). "Press Release: Publication of Pre-clinical Data of a Dual Targeting CAR for Treatment of Multiple Myeloma". London. 2018-01-02
Mallinckrodt plc. (12/26/17). "Press Release: Mallinckrodt to Acquire Sucampo Pharmaceuticals for approximately $1.2 Billion". Staines-upon-Thames & Rockville, MD. 2017-12-26
Orchard Therapeutics Ltd.. (12/20/17). "Press Release: Orchard Therapeutics Announces $110m Series B Financing to Advance Transformative Gene Therapy Pipeline". London. 2017-12-20
Coulter Partners. (12/19/17). "Press Release: Coulter Partners Secures CEO for Stevenage Bioscience Catalyst". 2017-12-19
Boehringer Ingelheim. (12/18/17). "Press Release: Autifony Therapeutics and Boehringer Ingelheim Collaborate on a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage & Ingelheim. 2017-12-18
TxCell S.A.. (12/18/17). "Press Release: TxCell Completes CAR-Treg Manufacturing Process Development and Provides Update to CMO Selection". Valbonne. 2017-12-18
German Accelerator Life Sciences. (12/18/17). "Press Release: German Accelerator Life Sciences (GALS) Partner Ada Health Expands to the US Upon Closing $47M Funding Round". 2017-12-18
Horizon Discovery Group plc. (12/18/17). "Press Release: Horizon Discovery Enters into Agreement with Roche Diagnostics to Support the Development of Immunohistochemistry Assays for Oncology". Cambridge. 2017-12-18
Stevenage Bioscience Catalyst. (12/15/17). "Press Release: Dr Sally Ann Forsyth Appointed CEO of Stevenage Bioscience Catalyst". Stevenage. 2017-12-15
Univercells S.A.. (12/15/17). "Press Release: Univercells Secures €3m Series A2 Funding". Gosselies. 2017-12-15
Orchard Therapeutics Ltd.. (12/15/17). "Press Release: Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease". London & Évry. 2017-12-15
Scancell Holdings plc. (12/14/17). "Press Release: Scancell and Cancer Research UK Collaborate to Advance Novel Cancer Immunotherapy into Clinical trials". 2017-12-14
Genedata AG. (12/12/17). "Press Release: Genedata and Titian Collaborate to Deliver Seamless Flow from Sample Inventory to Data Analysis". Basel & London. 2017-12-12
ProImmune Ltd.. (12/12/17). "Press Release: ProImmune Introduces MutaMap High-throughput Service for Mutational Activity Maps of Therapeutic Proteins". Oxford. 2017-12-12
Genomics Medicine Ireland Ltd.. (12/11/17). "Press Release: Genomics Medicine Ireland Research Study Aims to Unlock Answers to MS". Cork. 2017-12-11
Evotec AG. (12/11/17). "Press Release: Evotec’s Academic Bridge Lab282 with Oxford University Celebrating One Year of impact". Hamburg. 2017-12-11
Siemens AG. (12/11/17). "Press Release: Kingston Hospital NHS Foundation Trust Partners with Siemens Healthineers to Improve Efficiency by Transforming Radiology Department". Erlangen. 2017-12-11
ThromboGenics N.V.. (12/8/17). "Press Release: Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued Due to Slow Recruitment Rate". Leuven. 2017-12-08
bio.logis Genetic Information Management GmbH. (12/8/17). "Press Release: bio.logis GIM GmbH Concludes a Distribution Agreement with PGS.Holland BV". 2017-12-08
Pieris Pharmaceuticals, Inc.. (12/7/17). "Press Release: Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402". Boston, MA. 2017-12-07
Coulter Partners. (12/7/17). "Press Release: Coulter Partners Helps Secure Industry Leader, Dr Annalisa Jenkins as Chair for Cell Medica". 2017-12-07
Cell Medica Ltd.. (12/7/17). "Press Release: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair". 2017-12-07
Bluebird Bio, Inc.. (12/7/17). "Press Release: Bluebird Bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy". Cambridge, MA & Edinburgh. 2017-12-07
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
ERS Genomics Ltd.. (12/6/17). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Charles River". Dublin. 2017-12-06
Domainex Ltd.. (12/6/17). "Press Release: Domainex Appoints Chris Brown as Chief Financial Officer". Cambridge. 2017-12-06
ERS Genomics Ltd.. (12/5/17). "Press Release: Horizon Extends Industry-Leading Gene Editing IP Portfolio through Expansion of CRISPR License Rights with ERS Genomics". Dublin & Cambridge. 2017-12-05
Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes. 2017-12-05
Silence Therapeutics plc. (12/4/17). "Press Release: Partial Disposal of Arrowhead Common Shares". 2017-12-04
Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel. 2017-12-01
Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". 2017-11-30
Euronext N.V.. (11/29/17). "Press Release: Euronext Expands Its Federal Model with the Acquisition of the Irish Stock Exchange". Amsterdam, et al.. 2017-11-29
iOnctura S.A.. (11/28/17). "Press Release: iOnctura Announces Appointment of Leading International Scientific Advisory Board". Geneva. 2017-11-28
Owlstone Medical Ltd.. (11/27/17). "Press Release: Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial". Cambridge. 2017-11-27
Sphere Fluidics Ltd.. (11/27/17). "Press Release: Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant". Cambridge & Geneva. 2017-11-27
Euformatics Oy. (11/27/17). "Press Release: Euformatics Integrates AMP/ASCO/CAP Variant Guidelines Into omnomicsNGS". Espoo. 2017-11-27
LabGenius. (11/24/17). "Press Release: LabGenius Locks Down $3.66m from Top-tier Investors to Harness Evolution". London. 2017-11-24
Peak Scientific Instruments Ltd.. (11/23/17). "Press Release: Peak Upgrades to ISO 9001:2015". 2017-11-23
Symcel AB. (11/21/17). "Press Release: Symcel Secures €3.6m for Antibiotic Susceptibility Testing". 2017-11-21
Oxford Genetics Ltd.. (11/16/17). "Press Release: Oxford Genetics Licenses SnapFast Expression Vectors to Twist Bioscience". Oxford & San Francisco, CA. 2017-11-16
Curetis N.V.. (11/16/17). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months of 2017". Amsterdam & Holzgerlingen. 2017-11-16
Evox Therapeutics Ltd.. (11/16/17). "Press Release: Evox Therapeutics Appoints Antonin de Fougerolles as Chief Executive Officer". 2017-11-16
Mind the Byte S.L.. (11/15/17). "Press Release: Mind the Byte and Prosilico Sign a Strategic Partnership Agreement". 2017-11-15
Calliditas Therapeutics AB. (11/15/17). "Press Release: Pharmalink Is Renamed Calliditas Therapeutics". 2017-11-15
AstraZeneca plc. (11/15/17). "Press Release: Faslodex Receives US FDA Approval for the Treatment of Advanced Breast Cancer in Combination with Abemaciclib". 2017-11-15
PhoreMost Ltd.. (11/15/17). "Press Release: PhoreMost and Sixth Element Capital Announce Creation and Investment in NeoPhore, an Immuno-Oncology Company". Cambridge. 2017-11-15
AstraZeneca plc. (11/14/17). "Press Release: Fasenra (benralizumab) Receives US FDA Approval for Severe Eosinophilic Asthma". 2017-11-14
Biocartis Group N.V.. (11/14/17). "Press Release: Disclosure of a Transparency Notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings)". Mechelen. 2017-11-14
Quotient Sciences Ltd.. (11/14/17). "Press Release: Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization". Nottingham. 2017-11-14
AstraZeneca plc. (11/14/17). "Press Release: Faslodex (fulvestrant) Receives EU Approval for the Treatment of Hormone Receptor-positive Advanced Breast Cancer in Combination with Palbociclib". 2017-11-14
Immunocore Ltd.. (11/13/17). "Press Release: Immunocore Presents Single Agent IMCgp100 Data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate". Oxford & Conshohocken, PA. 2017-11-13
Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. 2017-11-13
Quotient Sciences Ltd.. (11/10/17). "Press Release: Quotient Sciences Launches as the New Global Identity for Quotient Clinical". Nottingham. 2017-11-10
DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. 2017-11-09
Peak Scientific Instruments Ltd.. (11/8/17). "Press Release: Peak Scientific Introduces New GC Gas Calculator". 2017-11-08
Evotec AG. (11/8/17). "Press Release: Evotec AG Announces First Nine-month 2017 Results and Corporate Update". Hamburg. 2017-11-08
Definiens AG. (11/8/17). "Press Release: Definiens Broadens Immuno-Oncology Service Offer. Predictive Multi-biomarkers for Accelerated Immuno-oncological Progress". Washington, D.C.. 2017-11-08
G1 Therapeutics, Inc.. (11/8/17). "Press Release: G1 Therapeutics Makes Key Executive Appointments. Barclay Phillips Appointed Chief Financial Officer and Senior Vice President, Corporate Development". Research Triangle Park, NC. 2017-11-08
Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London. 2017-11-08
Consilium Strategic Communications Ltd.. (11/7/17). "Press Release: Consilium Strategic Communications Strengthens Team with Three London Office Appointments". London. 2017-11-07
NousCom AG. (11/6/17). "Press Release: NousCom Raises €42 Million Series B Financing". Basel. 2017-11-06
Evotec AG. (11/6/17). "Press Release: Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build »NEPLEX«". Hamburg. 2017-11-06
Eurofins Scientific. (11/6/17). "Press Release: Eurofins Successfully Prices EUR 400m New Hybrid Bond". 2017-11-06
Goodwin Procter LLC. (11/6/17). "Press Release: Moderna and AstraZeneca Collaborate on Treatment for Heart Failure". 2017-11-06
Servier. (11/3/17). "Press Release: Egis Intensifies Its Acquisition Strategy in 2017". 2017-11-03
Medivir AB. (11/3/17). "Press Release: Medivir Appoints Erik Björk as Chief Financial Officer". Stockholm. 2017-11-03
Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg. 2017-11-02
Goodwin Procter LLC. (11/2/17). "Press Release: Ocera Therapeutics Acquired by Mallinckrodt for $42 Million". 2017-11-02
Moderna Therapeutics. (11/1/17). "Press Release: Moderna Announces New Collaboration with AstraZeneca to Co-develop and Co-commercialize Relaxin mRNA Therapeutic for Heart Failure". Cambridge, MA. 2017-11-01
Apitope International N.V.. (10/31/17). "Press Release: Apitope Announces Its Intention to Launch an Initial Public Offering and Listing on Euronext Brussels [Not for release in US, AU, CA, JP or any other jurisdiction where prohibited by applicable law] 2017-10-31
Dotmatics Ltd.. (10/31/17). "Press Release: Scottish Equity Partners Announces Investment in Dotmatics". London. 2017-10-31
ID Business Solutions Ltd.. (10/30/17). "Press Release: IDBS and Danaher Accelerate Innovation in Drug Development". Guildford. 2017-10-30
PerkinElmer, Inc.. (10/30/17). "Press Release: PerkinElmer Elects Pascale Witz to Its Board of Directors". Waltham, MA. 2017-10-30
Concept Life Sciences Holdings Ltd.. (10/30/17). "Press Release: Concept Life Sciences Announces Acquisition of Aquila BioMedical". Manchester. 2017-10-30
GlaxoSmithKline plc. (10/27/17). "Press Release: ViiV Healthcare Announces Positive Phase 3 results from the BRIGHTE Study of Fostemsavir in Heavily Treatment-experienced Patients with HIV". London. 2017-10-27
GlaxoSmithKline plc. (10/27/17). "Press Release: Public-private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One". San Francisco, CA. 2017-10-27
Akampion. (10/26/17). "Press Release: Akampion Hosts Expert Panel at BIO-Europe 2017, Co-authors Scientific Article in Human Gene Therapy". 2017-10-26
GlaxoSmithKline plc. (10/25/17). "Press Release: CDC’s Advisory Committee on Immunization Practices Recommends Shingrix as the Preferred Vaccine for the Prevention of Shingles for Adults Aged 50 and Up". London. 2017-10-25
GlaxoSmithKline plc. (10/25/17). "Press Release: GSK Delivers Q3 Sales of £7.8 billion, +4% AER, +2% CER". London. 2017-10-25
Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg. 2017-10-24
Qiagen N.V.. (10/24/17). "Press Release: Qiagen and ICMP Launch Next-generation DNA Testing Solutions for Identifying Missing Persons". The Hague. 2017-10-24
Ionicon Analytik GmbH. (10/24/17). "Press Release: Ionicon Presents the New Charon Aerosol Inlet for PTR-TOFMS". Innsbruck. 2017-10-24
Concept Life Sciences Holdings Ltd.. (10/24/17). "Press Release: Concept Life Sciences Appoints Philip Payne as Chief Commercial Officer". Manchester. 2017-10-24
Adaptimmune Therapeutics plc. (10/23/17). "Press Release: Sébastien Desprez Joins Adaptimmune as Vice President of Communications and Investor Relations". Philadeliphia, PA & Oxford. 2017-10-23
ADC Therapeutics S.A.. (10/23/17). "Press Release: ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials". Lausanne. 2017-10-23
next pagenext page 1 2 3 4 5 6 ... 41 42 43  next pagenext page


Picture [iito] – Putting Information into Context 600x102px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px

» top